Drugs/Procedures Used: During a 24-hour open-label run-in phase, a single dose of perindopril 2 mg will be adminstered to all patients. Patients were randomized to receive perindopril 2 mg/d (n ...

Patients with ejection fraction <40% were excluded. Patients were randomized to receive perindopril 2 mg daily or placebo. The primary outcome, the composite of all-cause mortality or unplanned ...

Angiotensin II type 1 and 2 receptors (AT 1 and AT 2 ... Over a period of 24 weeks, 10 patients with MFS received 8 mg perindopril daily, and 7 patients received placebo. Patients on perindopril ...